Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
A London company with a $250,000 federal grant fresh in hand is making sure those testing its radical new drug treatment for diabetes aren?t getting sick.
Sernova Corp. just won a patent for a new drug treatment, meaning those testing it in clinical trials won?t need anti-rejection medicine.
The patent is a big step to bringing the treatment to market, said Philip Toleikis, chief executive of Sernova.
?This is very important. It offers a non-toxic therapy for patients,? he said. ?I feel really good about this. We have a grant optimizing our technology and we have patent protection until 2027 ? that?s a long time.?
Sernova has developed a diabetes treatment in which a ?cell pouch? is implanted under the skin in a patient?s belly. Islets planted in the pouch produce insulin naturally in response to the patient?s blood-sugar levels.
http://www.chathamdailynews.ca/2013/07/04/london-firm-moving-ahead-with-approval-process
Sernova Corp. just won a patent for a new drug treatment, meaning those testing it in clinical trials won?t need anti-rejection medicine.
The patent is a big step to bringing the treatment to market, said Philip Toleikis, chief executive of Sernova.
?This is very important. It offers a non-toxic therapy for patients,? he said. ?I feel really good about this. We have a grant optimizing our technology and we have patent protection until 2027 ? that?s a long time.?
Sernova has developed a diabetes treatment in which a ?cell pouch? is implanted under the skin in a patient?s belly. Islets planted in the pouch produce insulin naturally in response to the patient?s blood-sugar levels.
http://www.chathamdailynews.ca/2013/07/04/london-firm-moving-ahead-with-approval-process